ZA96701B - 4-Mercaptobenzoylgaunidine derivatives - Google Patents

4-Mercaptobenzoylgaunidine derivatives

Info

Publication number
ZA96701B
ZA96701B ZA96701A ZA96701A ZA96701B ZA 96701 B ZA96701 B ZA 96701B ZA 96701 A ZA96701 A ZA 96701A ZA 96701 A ZA96701 A ZA 96701A ZA 96701 B ZA96701 B ZA 96701B
Authority
ZA
South Africa
Prior art keywords
mercaptobenzoylgaunidine
derivatives
mercaptobenzoylgaunidine derivatives
Prior art date
Application number
ZA96701A
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA96701B publication Critical patent/ZA96701B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Testing Resistance To Weather, Investigating Materials By Mechanical Methods (AREA)
ZA96701A 1995-01-31 1996-01-30 4-Mercaptobenzoylgaunidine derivatives ZA96701B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502895A DE19502895A1 (de) 1995-01-31 1995-01-31 4-Mercapto-benzoylguanidin-Derivate

Publications (1)

Publication Number Publication Date
ZA96701B true ZA96701B (en) 1997-04-16

Family

ID=7752677

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96701A ZA96701B (en) 1995-01-31 1996-01-30 4-Mercaptobenzoylgaunidine derivatives

Country Status (27)

Country Link
US (1) US5696167A (no)
EP (1) EP0725062B1 (no)
JP (1) JP3770947B2 (no)
CN (1) CN1058001C (no)
AR (1) AR002954A1 (no)
AT (1) ATE202088T1 (no)
AU (1) AU706843B2 (no)
BR (1) BR9600263A (no)
CA (1) CA2168319C (no)
CO (1) CO4700519A1 (no)
CZ (1) CZ290184B6 (no)
DE (2) DE19502895A1 (no)
DK (1) DK0725062T3 (no)
ES (1) ES2159652T3 (no)
FI (1) FI960423A (no)
GR (1) GR3036344T3 (no)
HU (1) HUP9600213A3 (no)
NO (1) NO305834B1 (no)
PL (1) PL181311B1 (no)
PT (1) PT725062E (no)
RU (1) RU2162079C2 (no)
SI (1) SI0725062T1 (no)
SK (1) SK281199B6 (no)
TR (1) TR199600067A2 (no)
TW (1) TW432036B (no)
UA (1) UA43345C2 (no)
ZA (1) ZA96701B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO2000030624A2 (en) * 1998-11-26 2000-06-02 Merck Patent Gmbh Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE158278T1 (de) * 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
TW250479B (no) * 1992-12-15 1995-07-01 Hoechst Ag
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AU706843B2 (en) 1999-06-24
HUP9600213A3 (en) 1998-07-28
HUP9600213A2 (en) 1997-01-28
CN1058001C (zh) 2000-11-01
ATE202088T1 (de) 2001-06-15
SK12896A3 (en) 1996-09-04
EP0725062A1 (de) 1996-08-07
TR199600067A2 (tr) 1996-08-21
DK0725062T3 (da) 2001-09-24
TW432036B (en) 2001-05-01
PL181311B1 (pl) 2001-07-31
JPH08245560A (ja) 1996-09-24
CZ27796A3 (en) 1996-10-16
FI960423A (fi) 1996-08-01
CO4700519A1 (es) 1998-12-29
SK281199B6 (sk) 2001-01-18
NO305834B1 (no) 1999-08-02
CN1134413A (zh) 1996-10-30
DE19502895A1 (de) 1996-08-01
CZ290184B6 (cs) 2002-06-12
PT725062E (pt) 2001-11-30
AR002954A1 (es) 1998-05-27
RU2162079C2 (ru) 2001-01-20
CA2168319C (en) 2007-03-06
UA43345C2 (uk) 2001-12-17
GR3036344T3 (en) 2001-11-30
CA2168319A1 (en) 1996-08-01
BR9600263A (pt) 1997-12-23
ES2159652T3 (es) 2001-10-16
HU9600213D0 (en) 1996-03-28
FI960423A0 (fi) 1996-01-30
DE59607055D1 (de) 2001-07-19
NO960392L (no) 1996-08-01
PL312544A1 (en) 1996-08-05
AU4220096A (en) 1996-08-08
JP3770947B2 (ja) 2006-04-26
US5696167A (en) 1997-12-09
EP0725062B1 (de) 2001-06-13
NO960392D0 (no) 1996-01-30
SI0725062T1 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB9508565D0 (en) Quiazoline derivative
GB2306473A8 (en) Glucoxide derivatives
ZA969990B (en) Oxymethoxy-3-aryl-pyrone derivatives
ZA96228B (en) Indolepiperidine derivatives
HU9603071D0 (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HUP9600107A3 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
ZA964470B (en) Cycloalkane-benzylidene derivatives
HK1003299A1 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
ZA96629B (en) 4-Aminobenzolylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
GB9516349D0 (en) Aza-anthracyclinone derivatives
ZA967204B (en) Alkenyl-benzoylguanidine derivatives
GR3036344T3 (en) 4-mercapto-benzoylguanidine derivatives
EP0804205A4 (en) 4-AZA-19-NORANDROSTANDERIVATE